Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Regulus Therapeutics - 13 Year Stock Price History | RGLS

Historical daily share price chart and data for Regulus Therapeutics since 2012 adjusted for splits and dividends. The latest closing stock price for Regulus Therapeutics as of June 11, 2025 is 8.15.
  • The all-time high Regulus Therapeutics stock closing price was 2649.60 on November 07, 2014.
  • The Regulus Therapeutics 52-week high stock price is 8.35, which is 2.5% above the current share price.
  • The Regulus Therapeutics 52-week low stock price is 0.83, which is 89.8% below the current share price.
  • The average Regulus Therapeutics stock price for the last 52 weeks is 2.37.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Regulus Therapeutics Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 3.2755 1.5600 8.3000 0.9700 8.1500 415.82%
2024 1.7850 1.3100 2.8800 1.1300 1.5800 23.44%
2023 1.3589 1.3600 1.7600 0.7929 1.2800 -6.57%
2022 2.0955 3.2800 3.3940 1.1700 1.3700 -56.51%
2021 9.3626 13.0000 19.6000 3.1500 3.1500 -76.67%
2020 7.2891 10.1000 15.1000 4.4000 13.5000 51.69%
2019 9.3422 11.1000 14.6000 5.1500 8.9000 -4.36%
2018 66.0429 135.6000 168.0000 8.3500 9.3060 -92.54%
2017 152.2022 276.0000 306.0000 99.1320 124.8000 -53.78%
2016 560.1714 1028.4000 1038.0000 264.0000 270.0000 -74.20%
2015 1444.7024 2062.8000 2535.6000 735.6000 1046.4000 -45.64%
2014 1149.0167 883.2000 2649.6000 696.0000 1924.8000 117.05%
2013 927.7690 766.8000 1489.2000 567.6000 886.8000 17.30%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.575B $0.000B
Regulus Therapeutics Inc. is a biopharmaceutical company focused on discovering and developing drugs that target microRNAs, called microRNA therapeutics. The Company's products aim to treat or prevent hepatitis C infections, cardiovascular disease, fibrosis, oncology, immuno-inflammatory diseases, and metabolic diseases. Regulus Therapeutics Inc. is based in La Jolla, California.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $86.949B 32.62
Zoetis (ZTS) United States $74.394B 27.76
Takeda Pharmaceutical (TAK) Japan $48.493B 9.65
Daiichi Sankyo, - (DSNKY) Japan $47.908B 24.55
BeOne Medicines - (ONC) Cayman Islands $28.843B 0.00
Sandoz Group AG (SDZNY) Switzerland $23.294B 0.00
Merck (MKKGY) Germany $17.183B 12.59
Summit Therapeutics (SMMT) United States $16.398B 0.00
Shionogi (SGIOY) Japan $14.377B 14.40
United Therapeutics (UTHR) United States $12.691B 11.23
Neurocrine Biosciences (NBIX) United States $12.348B 42.29
IPSEN (IPSEY) France $10.086B 0.00
Orion OYJ (ORINY) Finland $10.083B 27.27
Corcept Therapeutics (CORT) United States $7.664B 62.30
Stevanato Group S.p.A (STVN) Italy $7.462B 45.63
Madrigal Pharmaceuticals (MDGL) United States $6.268B 0.00
Grifols, S.A (GRFS) Spain $6.202B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Ionis Pharmaceuticals (IONS) United States $5.863B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.980B 15.15
Soleno Therapeutics (SLNO) United States $4.021B 0.00
Catalyst Pharmaceuticals (CPRX) United States $3.209B 11.24
Hypermarcas (HYPMY) Brazil $3.110B 20.46
Crinetics Pharmaceuticals (CRNX) United States $3.097B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.452B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.448B 13.24
BioCryst Pharmaceuticals (BCRX) United States $2.304B 0.00
Recursion Pharmaceuticals (RXRX) United States $2.215B 0.00
Indivior (INDV) United States $1.888B 8.01
Dyne Therapeutics (DYN) United States $1.680B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.619B 0.00
Evotec AG (EVO) Germany $1.467B 0.00
ARS Pharmaceuticals (SPRY) United States $1.443B 0.00
Ocular Therapeutix (OCUL) United States $1.419B 0.00
Guardian Pharmacy Services (GRDN) United States $1.306B 0.00
Harrow (HROW) United States $1.143B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.101B 22.03
Enliven Therapeutics (ELVN) United States $1.065B 0.00
Akebia Therapeutics (AKBA) United States $1.030B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.990B 0.00
Collegium Pharmaceutical (COLL) United States $0.976B 5.26
Ardelyx (ARDX) United States $0.895B 0.00
Cronos Group (CRON) Canada $0.752B 0.00
Elite Pharmaceuticals (ELTP) United States $0.748B 0.00
Xeris Biopharma Holdings (XERS) United States $0.712B 0.00
KalVista Pharmaceuticals (KALV) United States $0.706B 0.00
Xencor (XNCR) United States $0.693B 0.00
Relay Therapeutics (RLAY) United States $0.598B 0.00
AleAnna (ANNA) United States $0.584B 0.00
Liminatus Pharma (LIMN) United States $0.583B 0.00
USANA Health Sciences (USNA) United States $0.575B 12.49
Verve Therapeutics (VERV) United States $0.569B 0.00
Bioventus (BVS) United States $0.564B 14.29
Altimmune (ALT) United States $0.547B 0.00
Theravance Biopharma (TBPH) United States $0.537B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.513B 0.00
Zevra Therapeutics (ZVRA) United States $0.507B 0.00
Oruka Therapeutics (ORKA) United States $0.494B 0.00
Tourmaline Bio (TRML) United States $0.488B 0.00
Siga Technologies (SIGA) United States $0.444B 9.28
Organogenesis (ORGO) United States $0.440B 0.00
Savara (SVRA) United States $0.403B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.385B 10.41
Aquestive Therapeutics (AQST) United States $0.356B 0.00
Heron Therapeutics (HRTX) United States $0.323B 0.00
ProKidney (PROK) United States $0.293B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.276B 0.00
Nature's Sunshine Products (NATR) United States $0.264B 24.24
Esperion Therapeutics (ESPR) United States $0.242B 0.00
MediWound (MDWD) Israel $0.230B 0.00
Nanobiotix S.A (NBTX) France $0.229B 0.00
4D Molecular Therapeutics (FDMT) United States $0.207B 0.00
Profound Medical (PROF) Canada $0.203B 0.00
OmniAb (OABI) United States $0.188B 0.00
Larimar Therapeutics (LRMR) United States $0.186B 0.00
Journey Medical (DERM) United States $0.170B 0.00
Aclaris Therapeutics (ACRS) United States $0.164B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.162B 0.00
Aldeyra Therapeutics (ALDX) United States $0.161B 0.00
Lyell Immunopharma (LYEL) United States $0.160B 0.00
Avita Medical (RCEL) United States $0.158B 0.00
Lexeo Therapeutics (LXEO) United States $0.153B 0.00
Inhibikase Therapeutics (IKT) United States $0.149B 0.00
Korro Bio (KRRO) United States $0.149B 0.00
Nektar Therapeutics (NKTR) United States $0.141B 0.00
Protara Therapeutics (TARA) United States $0.130B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.129B 0.00
Achieve Life Sciences (ACHV) Canada $0.128B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
Cardiol Therapeutics (CRDL) Canada $0.120B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.113B 0.00
Fractyl Health (GUTS) United States $0.106B 0.00
Cassava Sciences (SAVA) United States $0.105B 0.00
Wellgistics Health (WGRX) United States $0.102B 0.00
Inotiv (NOTV) United States $0.098B 0.00
OptiNose (OPTN) United States $0.097B 0.00
VAXART, INC (VXRT) United States $0.090B 0.00
Arch Biopartners (ACHFF) Canada $0.090B 0.00
Champions Oncology (CSBR) United States $0.089B 14.68
Nutriband (NTRB) United States $0.086B 0.00
Galectin Therapeutics (GALT) United States $0.085B 0.00
Pyxis Oncology (PYXS) United States $0.083B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.082B 61.22
Dominari Holdings (DOMH) United States $0.080B 0.00
Surrozen (SRZN) United States $0.077B 0.00
ESSA Pharma (EPIX) Canada $0.076B 0.00
Rafael Holdings (RFL) United States $0.071B 0.00
Vivani Medical (VANI) United States $0.069B 0.00
Klotho Neurosciences (KLTO) United States $0.065B 0.00
Unicycive Therapeutics (UNCY) United States $0.064B 0.00
Assertio Holdings (ASRT) United States $0.063B 0.00
NRx Pharmaceuticals (NRXP) United States $0.063B 0.00
PMV Pharmaceuticals (PMVP) United States $0.062B 0.00
Telomir Pharmaceuticals (TELO) United States $0.061B 0.00
Prelude Therapeutics (PRLD) United States $0.061B 0.00
Context Therapeutics (CNTX) United States $0.060B 0.00
Metagenomi (MGX) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Gain Therapeutics (GANX) United States $0.057B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.056B 0.00
Century Therapeutics (IPSC) United States $0.055B 0.00
Avalo Therapeutics (AVTX) United States $0.052B 0.00
Carisma Therapeutics (CARM) United States $0.046B 0.00
Mural Oncology (MURA) Ireland $0.044B 0.00
ElectroCore (ECOR) United States $0.043B 0.00
Iterum Therapeutics (ITRM) Ireland $0.042B 0.00
Acrivon Therapeutics (ACRV) United States $0.040B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.039B 0.00
Karyopharm Therapeutics (KPTI) United States $0.038B 0.00
PolyPid (PYPD) Israel $0.036B 0.00
SCYNEXIS (SCYX) United States $0.034B 0.00
China SXT Pharmaceuticals (SXTC) China $0.033B 0.00
Tempest Therapeutics (TPST) United States $0.033B 0.00
Jupiter Neurosciences (JUNS) United States $0.032B 0.00
FibroGen (FGEN) United States $0.031B 0.00
Relmada Therapeutics (RLMD) United States $0.026B 0.00
CASI Pharmaceuticals (CASI) China $0.023B 0.00
Enlivex Therapeutics (ENLV) Israel $0.023B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
Lyra Therapeutics (LYRA) United States $0.021B 0.00
BioVie (BIVI) United States $0.020B 0.00
Mannatech (MTEX) United States $0.020B 0.00
BioLineRx (BLRX) Israel $0.019B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.019B 0.00
DURECT (DRRX) United States $0.018B 0.00
Lipocine (LPCN) United States $0.018B 0.00
Scienture Holdings (SCNX) United States $0.015B 0.00
VYNE Therapeutics (VYNE) United States $0.015B 0.00
ProPhase Labs (PRPH) United States $0.015B 0.00
Cosmos Health (COSM) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.014B 0.00
Minerva Neurosciences (NERV) United States $0.013B 2.20
Vivos Therapeutics (VVOS) United States $0.012B 0.00
Ainos (AIMD) United States $0.012B 0.00
Phio Pharmaceuticals (PHIO) United States $0.012B 0.00
GlycoMimetics (GLYC) United States $0.011B 0.00
Citius Pharmaceuticals (CTXR) United States $0.011B 0.00
Mangoceuticals (MGRX) United States $0.011B 0.00
Talphera (TLPH) United States $0.010B 0.00
Traws Pharma (TRAW) United States $0.010B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.010B 0.00
Ernexa Therapeutics (ERNA) United States $0.010B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.009B 0.00
SHINECO (SISI) China $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
Incannex Healthcare (IXHL) Australia $0.006B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Plus Therapeutics (PSTV) United States $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.006B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Alaunos Therapeutics (TCRT) United States $0.005B 0.00
Indaptus Therapeutics (INDP) United States $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Redhill Biopharma (RDHL) Israel $0.005B 0.00
PainReform (PRFX) Israel $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
Heatwurx (PCSA) United States $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.003B 0.00
Aditxt (ADTX) United States $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
TNF Pharmaceuticals (TNFA) United States $0.003B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00